The effect of an anti-VEGF drug on proliferative retinopathy.
Not Applicable
- Conditions
- Diabetic retinopathy
- Registration Number
- JPRN-jRCTs031180307
- Lead Sponsor
- Kitano Shigehiko
- Brief Summary
Intravitreal injection of aflibercept did not change the area of the non-perfusion area of the retina.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 2
Inclusion Criteria
Diabetic retinopathy with macular edema and non-perfusion area
Exclusion Criteria
Posttreatment for diabetic retinopath
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of non-perfusion area
- Secondary Outcome Measures
Name Time Method Change of visual acuity, retinal thickness and neovascularization